Advanced search
Publication Cover
OncoImmunology Volume 5, 2016 - Issue 8
Submit an article Journal homepage
1,245
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination

Steve BoudewijnsDepartment of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands;Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
,
Rutger H. T. KoornstraDepartment of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands
,
Harm WestdorpDepartment of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands;Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
,
Gerty SchreibeltDepartment of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
,
Alfons J. M. van den EertweghDepartment of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands
,
Marnix H. Geukes FoppenDepartment of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands
,
John B. HaanenDepartment of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands
,
I. Jolanda M. de VriesDepartment of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands;Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
,
Carl G. FigdorDepartment of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
,
Kalijn F. BolDepartment of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands;Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
&
Winald R. GerritsenDepartment of Medical Oncology, Radboud University Medical Centre, Nijmegen, the NetherlandsCorrespondence[email protected]
 show all
Article: e1201625 | Received 18 Apr 2016, Accepted 09 Jun 2016, Published online: 13 Aug 2016

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Wouter W. van Willigen, Martine Bloemendal, Marye J. Boers-Sonderen, Jan Willem B. de Groot, Rutger H.T. Koornstra, Astrid A.M. van der Veldt, John B. A. G. Haanen, Steve Boudewijns, Gerty Schreibelt, Winald R. Gerritsen, I. Jolanda M. de Vries & Kalijn F. Bol. (2020) Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination. OncoImmunology 9:1.
Read now
David J. Chung, Richard D. Carvajal, Michael A. Postow, Sneh Sharma, Katherine B. Pronschinske, Justin A. Shyer, Shahnaz Singh-Kandah, Mark A. Dickson, Sandra P. D'Angelo, Jedd D. Wolchok & James W. Young. (2018) Langerhans-type dendritic cells electroporated with TRP-2 mRNA stimulate cellular immunity against melanoma: Results of a phase I vaccine trial. OncoImmunology 7:1.
Read now
Abhishek D. Garg, Sanket More, Nicole Rufo, Odeta Mece, Maria Livia Sassano, Patrizia Agostinis, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2017) Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics. OncoImmunology 6:12.
Read now

Articles from other publishers (17)

Yongchao Zhang, Bozhi Liu, Sergei Kotenko & Wei Li. (2022) Prognostic value of neutrophil-lymphocyte ratio and lactate dehydrogenase in melanoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis. Medicine 101:32, pages e29536.
Crossref
Farid Ghorbaninezhad, Zahra Asadzadeh, Javad Masoumi, Ahad Mokhtarzadeh, Tohid Kazemi, Leili Aghebati-Maleki, Siamak Sandoghchian Shotorbani, Mahdi Abdoli Shadbad, Amir Baghbanzadeh, Nima Hemmat, Mohammad Bakhshivand & Behzad Baradaran. (2022) Dendritic cell-based cancer immunotherapy in the era of immune checkpoint inhibitors: From bench to bedside. Life Sciences 297, pages 120466.
Crossref
Cornelia Amalinei, Adriana Grigoraș, Ludmila Lozneanu, Irina-Draga Căruntu, Simona-Eliza Giușcă & Raluca Anca Balan. (2022) The Interplay between Tumour Microenvironment Components in Malignant Melanoma. Medicina 58:3, pages 365.
Crossref
Liwei Zhao, Shuai Zhang, Oliver Kepp, Guido Kroemer & Peng Liu. 2022. Adoptive Cell Transfer. Adoptive Cell Transfer 33 64 .
Iwona Kwiecień, Elżbieta Rutkowska, Agata Raniszewska, Piotr Rzepecki & Joanna Domagała-Kulawik. (2021) Modulation of the immune response by heterogeneous monocytes and dendritic cells in lung cancer. World Journal of Clinical Oncology 12:11, pages 966-982.
Crossref
Sara Nava, Daniela Lisini, Simona Frigerio & Anna Bersano. (2021) Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect. International Journal of Molecular Sciences 22:22, pages 12339.
Crossref
Gonzalo Tapia Rico, Chen Han Yong & Ruth Gabriela Herrera Gómez. (2021) Adjuvant systemic treatment for high-risk resected non-cutaneous melanomas: What is the evidence?. Critical Reviews in Oncology/Hematology 167, pages 103503.
Crossref
Emma Probst Brandum, Astrid Sissel Jørgensen, Mette Marie Rosenkilde & Gertrud Malene Hjortø. (2021) Dendritic Cells and CCR7 Expression: An Important Factor for Autoimmune Diseases, Chronic Inflammation, and Cancer. International Journal of Molecular Sciences 22:15, pages 8340.
Crossref
Tianyu Tang, Xing Huang, Gang Zhang, Zhengtao Hong, Xueli Bai & Tingbo Liang. (2021) Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy. Signal Transduction and Targeted Therapy 6:1.
Crossref
Yaoyao Shi, Katarzyna Tomczak, June Li, Joshua K. Ochieng, Younghee Lee & Cara Haymaker. (2021) Next-Generation Immunotherapies to Improve Anticancer Immunity. Frontiers in Pharmacology 11.
Crossref
Mona Kamal Saadeldin, Amal Kamal Abdel-Aziz & Ahmed Abdellatif. (2021) Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis. Medical Hypotheses 146, pages 110365.
Crossref
Fleury Augustin Nsole Biteghe, Nyangone Ekome Toung Chalomie, Neelakshi Mungra, Guillaume Vignaux, Nan Gao, Aurelia Vergeade, Ambrose Okem, Krupa Naran, Jean De La Croix Ndong & Stefan Barth. (2020) Antibody-Based Immunotherapy: Alternative Approaches for the Treatment of Metastatic Melanoma. Biomedicines 8:9, pages 327.
Crossref
Fausto Petrelli, Raffaele Ardito, Barbara Merelli, Veronica Lonati, Mary Cabiddu, Silvia Seghezzi, Sandro Barni & Antonio Ghidini. (2019) Prognostic and predictive role of elevated lactate dehydrogenase in patients with melanoma treated with immunotherapy and BRAF inhibitors: a systematic review and meta-analysis. Melanoma Research 29:1, pages 1-12.
Crossref
Mandy van Gulijk, Floris Dammeijer, Joachim G. J. V. Aerts & Heleen Vroman. (2018) Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy. Frontiers in Immunology 9.
Crossref
Wouter W. van Willigen, Martine Bloemendal, Winald R. Gerritsen, Gerty Schreibelt, I. Jolanda M. de Vries & Kalijn F. Bol. (2018) Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time. Frontiers in Immunology 9.
Crossref
Larisa J. Geskin, James J. Damiano, Christina C. Patrone, Lisa H. Butterfield, John M. Kirkwood & Louis D. Falo. (2018) Three antigen-loading methods in dendritic cell vaccines for metastatic melanoma. Melanoma Research 28:3, pages 211-221.
Crossref
. (2016) Ipilimumab. Reactions Weekly 1623:1, pages 113-113.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.